Kathryn Greven to Female
This is a "connection" page, showing publications Kathryn Greven has written about Female.
Connection Strength
0.264
-
Hughes RT, Beuerlein WJ, O'Neill SS, Porosnicu M, Lycan TW, Waltonen JD, Frizzell BA, Greven KM. Human papillomavirus-associated squamous cell carcinoma of the larynx or hypopharynx: Clinical outcomes and implications for laryngeal preservation. Oral Oncol. 2019 11; 98:20-27.
Score: 0.044
-
Saconn PA, Gee CJ, Greven CM, McCoy TP, Ekstrand KE, Greven KM. Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study. Int J Radiat Oncol Biol Phys. 2010 Nov 01; 78(3):844-8.
Score: 0.023
-
Greven KM. Resolving the confusion surrounding adjuvant radiation in endometrial cancer. Oncology (Williston Park). 2009 Apr 15; 23(4):353, 356.
Score: 0.021
-
Greven KM, White DR, Browne JD, Williams DW, McGuirt WF, D'Agostino RB. Swallowing dysfunction is a common sequelae after chemoradiation for oropharynx carcinoma. Am J Clin Oncol. 2008 Jun; 31(3):209-12.
Score: 0.020
-
Greven KM, Williams DW, Browne JD, McGuirt WF, White DR, D'Agostino RB. Radiographic complete response on post treatment CT imaging eliminates the need for adjuvant neck dissection after treatment for node positive head and neck cancer. Am J Clin Oncol. 2008 Apr; 31(2):169-72.
Score: 0.020
-
Gaffney DK, Winter K, Dicker AP, Miller B, Eifel PJ, Ryu J, Avizonis V, Fromm M, Small W, Greven K. Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128. Int J Radiat Oncol Biol Phys. 2007 Sep 01; 69(1):111-7.
Score: 0.019
-
Gaffney DK, Winter K, Dicker AP, Miller B, Eifel PJ, Ryu J, Avizonis V, Fromm M, Greven K. A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128. Int J Radiat Oncol Biol Phys. 2007 Jan 01; 67(1):104-9.
Score: 0.018
-
Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T. Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol. 2006 Oct; 103(1):155-9.
Score: 0.017
-
Sunwook K, Nussbaum MA, Quandt SA, Laurienti PJ, Arcury TA. Effects of Lifetime Occupational Pesticide Exposure on Postural Control Among Farmworkers and Non-Farmworkers. J Occup Environ Med. 2016 Feb; 58(2):133-9.
Score: 0.017
-
Greven KM, Paunesku T. Radiation complications of the pelvis. Cancer Treat Res. 2006; 128:125-53.
Score: 0.017
-
Greven KM. Is a "Puff to the Cuff" enough?: In regard to Alektiar et al. (Int J Radiat Oncol Biol Phys 2005;62: 111-117). Int J Radiat Oncol Biol Phys. 2005 Nov 15; 63(4):1275; author reply 1275.
Score: 0.017
-
Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer. Int J Radiat Oncol Biol Phys. 2004 May 01; 59(1):168-73.
Score: 0.015
-
Klopp A, Smith BD, Alektiar K, Cabrera A, Damato AL, Erickson B, Fleming G, Gaffney D, Greven K, Lu K, Miller D, Moore D, Petereit D, Schefter T, Small W, Yashar C, Viswanathan AN. The role of postoperative radiation therapy for endometrial cancer: Executive summary of an American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol. 2014 May-Jun; 4(3):137-144.
Score: 0.007
-
Rustin GJ, Vergote I, Eisenhauer E, Pujade-Lauraine E, Quinn M, Thigpen T, du Bois A, Kristensen G, Jakobsen A, Sagae S, Greven K, Parmar M, Friedlander M, Cervantes A, Vermorken J. Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG). Int J Gynecol Cancer. 2011 Feb; 21(2):419-23.
Score: 0.006
-
Rustin GJ, Quinn M, Thigpen T, du Bois A, Pujade-Lauraine E, Jakobsen A, Eisenhauer E, Sagae S, Greven K, Vergote I, Cervantes A, Vermorken J. Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer). J Natl Cancer Inst. 2004 Mar 17; 96(6):487-8.
Score: 0.004